NL-OMON31476
Completed
Not Applicable
Duloxetine plus collaborative care treatment versus Duloxetine alone in the treatment of concomitant pain and depressive disorder. A randomized clinical trial in primary care. - CC:PAINDIP (collaborative care: pain depression in primary healthcare)
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- pijnklachten
- Sponsor
- Trimbos instituut
- Enrollment
- 116
- Status
- Completed
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients will be selected that have presented themselves with pain at their primary care physician. They will be approached for the study and asked informed consent. If they consent, they will be screened with the PHQ for depressive disorder and the BPI (brief pain inventory). In case of a cut\-off score of \>10 on the PHQ and a score of \>\= 3 on the 'average pain' item of the BPI, they will be included in the study.
Exclusion Criteria
- •Exclusion criteria will be: cancer; recent post traumatic pain; alcohol or drug abuse; suicidal ideation; psychotic symptoms; dementia; somatization disorder; or already being under psychiatric treatment. Also, all contraindications known by the PCP for Duloxetine will be exclusion criteria as well.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The effect of Deluxitine on the negative symptoms of schizophreniaIRCT20191218045795N2Sanandaj University of Medical Sciences44
Completed
Phase 2
Duloxetine in patients with schizophreniaschizophrenia.schizophreniaIRCT201506201556N77Tehran University of Medical Sciences50
Completed
Not Applicable
Doluxetine add on conventional treatment in in?ammatory bowel disease patientsCondition 1: In?ammatory bowel disease. Condition 2: In?ammatory bowel disease.Crohn disease [regional enteritis]Ulcerative colitisIRCT201411127841N8Isfahan University of Medical Sciences, Psychosomatic Research Center40
Completed
Not Applicable
Efficacy and complication of Duloxetine in attention deficeit –hyperactivity disorder (ADHD) and comparison with RitaliIRCT201110127462N2Tehran University of Medical Sciences40
Completed
Phase 4
Duloxetine Versus Duloxetine Plus Non-Drug Therapy for DepressionDepressionNCT00494377Eli Lilly and Company940